Gaborone

Gaborone is rapidly transforming into a premier life sciences hub, uniquely positioned at the intersection of pharmaceutical manufacturing and specialized biotechnology research.

The city is best known for its strategic investment in genomic sequencing and the development of a state-of-the-art biopharmaceutical pilot plant, which aims to bolster regional vaccine production and supply chain resilience.

As the home of the Botswana Digital & Innovation Hub (BDIH), Gaborone fosters a thriving healthcare innovation ecosystem where startups leverage CRISPR-Cas9 technology and AI-driven diagnostics to address both local and global health challenges.

The capital’s academic research sector is anchored by prestigious institutions that collaborate on international clinical trials, particularly in infectious diseases and indigenous knowledge systems for alternative medicine.

Within the Sir Seretse Khama International Airport Special Economic Zone (SSKIA-SEZ), the city offers lucrative incentives for medical device manufacturers specializing in high-value, low-volume diagnostic equipment and biomedical engineering.

Gaborone's commitment to regulatory excellence and intellectual property protection makes it an attractive destination for foreign direct investment (FDI) in the biopharma sector.

By integrating precision medicine with a robust distribution network, Gaborone is solidifying its reputation as a central gateway for healthcare technology across the SADC region.